Masters of Health Magazine September 2018 - Page 45

Celiac Disease, Gluten Intolerance and the Shikimate Pathway

Celiac disease and gluten intolerance is characterised by symptoms of nausea, diarrhoea, skin rashes, macrocytic anaemia and depression. In their ground-breaking research into celiac disease and gluten intolerance, scientists Stephanie Seneff and Anthony Samsel reported an associated pathology of inflammatory response in the upper small intestine, leading to a flattening of the microvilli, impairing their ability and important role of absorbing nutrients. Furthermore, undiagnosed celiac disease is associated with a 4-fold increased risk of death, mostly due to increased cancer risk. [2]

In Monsanto’s own studies, soybeans showed a seven-fold increase of trypsin inhibitor which, if eaten, would give a patient gas and bloating. Gut dysbiosis and gluten intolerance are notably common bio-markers in Autism Spectrum Disorders (ASD) and other mental health issues. [3] Samsel and Seneff also published a graph linking the incidence of autism growing in line with growth in the use of glyphosate.

The severity of glyphosate damage to living organisms is expressed via its disruption and inhibition of the Shikimate enzyme pathway in bacteria and plants – a pathway human cells (apparently) don’t have. It was promoted by Monsanto that this was the reason humans would be immune to the toxic effects of Glyphosate. However it turns out that nothing could be further from the truth.

Humans depend on beneficial bacteria (which respire using the Shikimate enzyme pathway) for digestion and absorption of nutrients, synthesis of vitamins (including B12), detoxifying harmful chemicals, improving intestinal permeability and increasing the defences of the immune system. If this system is choked via blocking of respiration and metabolism, the bacteria die and the gut can become victim to overgrowth of pathogenic bacteria that are more resilient to the effects of glyphosate.